ASBMR President Douglas P. Kiel, M.D., M.P.H. Issues Statement Regarding the New England Journal of Medicine Article “Postmenopausal Osteoporosis”
Date: January 27, 2016
Last week, an article featured in The New England Journal of Medicine highlighted the benefits of using bisphosphonates and other proven drug therapies in treating patients with low bone mineral density to prevent fractures despite rare potential risks. ASBMR President Douglas P. Kiel, M.D., M.P.H. issued a response, stating the following:
“This thoughtful review of osteoporosis is another wake up call to health care providers that patients with this disease are not being screened and treated despite the fact that we have excellent screening tools and effective drugs to prevent fractures.”
Read his full statement, along with a summary of the article, on the ASBMR website.